Trial Profile
A pilot study evaluating sofosbuvir-based anti-viral regimen for the treatment of chronic hepatitis C virus (HCV) infection in kidney transplant recipients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Nov 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Daclatasvir; Ledipasvir/sofosbuvir; Peginterferon alfa-2a; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Therapeutic Use
- 29 Nov 2015 New trial record
- 20 Nov 2015 Results published in the American Journal of Transplantation